MIAMI, Oct. 21, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised OPKO Health, Inc., a multinational biopharmaceutical company, on its agreement to sell select assets of its wholly owned subsidiary, BioReference Health, LLC, to Labcorp.

The purchase price for the transaction is $722 million in cash at closing, subject to an upward or downward adjustment based on closing business revenues, according to OPKO's press release. The agreement also provides for up to an additional $150 million earnout based on revenue from the 4Kscore® Test, an FDA-approved blood test that helps predict the likelihood of finding aggressive prostate cancer before a biopsy decision. The transaction is subject to regulatory approvals and customary closing conditions.

As part of the agreement, Labcorp will acquire BioReference Health's laboratory testing businesses focused on clinical and women's health testing services, urology, corrections, and certain operational assets, including more than 80 patient service centers.

The Greenberg Traurig deal team was led by Miami Corporate Practice Co-Chair Drew M. Altman and Shareholder Guillaume Le Masson.

Corporate Practice Shareholder Robert L. Grossman advised on the deal. Grossman is past chair of the firm's Israel practice, which he helped build and lead for more than 20 years.

"We value our longstanding relationship with OPKO and appreciate the trust they placed in us on this transaction," said Corporate Practice Shareholder Robert L. Grossman, who advised on the deal. "This matter reflects the commitment, talent, and hard work of both the OPKO team and the multidisciplinary Greenberg Traurig lawyers who worked together across practices and offices."

The team also included Miami Tax Shareholder L. Frank Cordero; Houston Health Care & FDA Shareholders Nicholas J. Diamond, Ph.D., and Charles C. Dunham, IV; New York Intellectual Property & Technology Shareholder David M. Greenberg; Washington, D.C., Antitrust & Competition Shareholder Justin P. Hedge; New York Antitrust & Competition Shareholder Stephen M. Pepper; Washington, D.C., Government Contracts Shareholder Melissa P. Prusock; Miami Tax Shareholder Leanne Reagan; Miami Intellectual Property & Technology Shareholder Manuel R. Valcarcel IV; Atlanta Labor & Employment Shareholder Natasha L. Wilson; and Washington, D.C., Corporate Of Counsel Rebecca Tracy Rotem.

Other team members included Philadelphia Intellectual Property & Technology Associate Sukhdeep S. Gill; Miami Corporate Associate Ashelin Myus; Washington, D.C., Corporate Associate Macy K. Nix; and Miami Tax Associate Maria Walker.

About Greenberg Traurig: Greenberg Traurig, LLP has approximately 3,200 lawyers across 51 locations in the United States, Europe, the Middle East, Latin America, and Asia. The firm's broad geographic and practice range enables the delivery of innovative and strategic legal services across borders and industries. Recognized as a 2025 BTI "Best of the Best Recommended Law Firm" by general counsel for trust and relationship management, Greenberg Traurig is consistently ranked among the top firms on the Am Law Global 100, NLJ 500, and Law360 400. Greenberg Traurig is also known for its philanthropic giving, culture, innovation, and pro bono work. Web: www.gtlaw.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/greenberg-traurig-advises-opko-health-on-722m-agreement-to-sell-select-bioreference-health-assets-to-labcorp-302915762.html

SOURCE Greenberg Traurig, LLP